×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Swedish Orphan Biovitrum (BIOVF) Beats Q2 Earnings and Revenue Estimates
Yahoo News New Zealand
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 27.27% and 16.48%, respectively, for the quarter ended June...
5 days ago
Here's Why Shareholders May Consider Paying Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) CEO A Little More
Simply Wall Street
Key Insights Swedish Orphan Biovitrum's Annual General Meeting to take place on 14th of May Total pay for CEO Guido...
2 weeks ago
Interim Report Q4 2023
Sobi
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2023. Fourth Quarter 2023.
3 months ago
Sobi Earnings: In-Line Q3 Results Driven by Hematology and Immunology, Maintaining Our FVE
Morningstar
Sobi SOBI reported third-quarter results that were in line with our expectations, and we're maintaining our SEK 252 fair value estimate as...
6 months ago
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sees Significant Growth in Short Interest
Defense World
Read Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sees Significant Growth in Short Interest at Defense World.
1 week ago
Bulletin from Sobi's Annual General Meeting (AGM)
KFOR
STOCKHOLM, May 14, 2024 /PRNewswire/ -- The Swedish Orphan Biovitrum AB (publ) (Sobi®) AGM was convened today on 14 May 2024.
1 week ago
Sobi submits application for Orfadin® oral suspension to FDA
Yahoo Life UK
Swedish Orphan Biovitrum AB (publ) (Sobi) announced today that the company`s application for Orfadin oral suspension has been submitted to the US Food and...
1 day ago
Experimental CAD therapy pegcetacoplan halted by developers
Cold Agglutinin Disease News
Apellis Pharmaceuticals and Swedish Orphan Biovitrum (Sobi) have stopped the clinical development of the experimental therapy pegcetacoplan...
2 months ago
Sweden's Sobi issues notes to raise up to a billion dollars
The Pharma Letter
Swedish Orphan Biovitrum, a rare disease company also known as Sobi, is set to raise around 10 billion Swedish kroner ($920 million) in...
3 weeks ago